633 related articles for article (PubMed ID: 21667074)
1. Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats.
Klein C; Karanges E; Spiro A; Wong A; Spencer J; Huynh T; Gunasekaran N; Karl T; Long LE; Huang XF; Liu K; Arnold JC; McGregor IS
Psychopharmacology (Berl); 2011 Nov; 218(2):443-57. PubMed ID: 21667074
[TBL] [Abstract][Full Text] [Related]
2. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic and behavioural profile of THC, CBD, and THC+CBD combination after pulmonary, oral, and subcutaneous administration in rats and confirmation of conversion in vivo of CBD to THC.
Hložek T; Uttl L; Kadeřábek L; Balíková M; Lhotková E; Horsley RR; Nováková P; Šíchová K; Štefková K; Tylš F; Kuchař M; Páleníček T
Eur Neuropsychopharmacol; 2017 Dec; 27(12):1223-1237. PubMed ID: 29129557
[TBL] [Abstract][Full Text] [Related]
4. Effect of low doses of delta9-tetrahydrocannabinol and cannabidiol on the extinction of cocaine-induced and amphetamine-induced conditioned place preference learning in rats.
Parker LA; Burton P; Sorge RE; Yakiwchuk C; Mechoulam R
Psychopharmacology (Berl); 2004 Sep; 175(3):360-6. PubMed ID: 15138755
[TBL] [Abstract][Full Text] [Related]
5. Interactions between cannabidiol and Δ
Todd SM; Zhou C; Clarke DJ; Chohan TW; Bahceci D; Arnold JC
Eur Neuropsychopharmacol; 2017 Feb; 27(2):132-145. PubMed ID: 28043732
[TBL] [Abstract][Full Text] [Related]
6. An assessment of concurrent cannabidiol and Δ⁹-tetrahydrocannabinol administration in place aversion and taste avoidance conditioning.
Hempel BJ; Clasen MM; Nelson KH; Woloshchuk CJ; Riley AL
Exp Clin Psychopharmacol; 2018 Apr; 26(2):205-213. PubMed ID: 29648861
[TBL] [Abstract][Full Text] [Related]
7. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
8. Interactions between THC and cannabidiol in mouse models of cannabinoid activity.
Varvel SA; Wiley JL; Yang R; Bridgen DT; Long K; Lichtman AH; Martin BR
Psychopharmacology (Berl); 2006 Jun; 186(2):226-34. PubMed ID: 16572263
[TBL] [Abstract][Full Text] [Related]
9. Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.
Vann RE; Gamage TF; Warner JA; Marshall EM; Taylor NL; Martin BR; Wiley JL
Drug Alcohol Depend; 2008 Apr; 94(1-3):191-8. PubMed ID: 18206320
[TBL] [Abstract][Full Text] [Related]
10. Female but not male rats show biphasic effects of low doses of Δ
Salviato BZ; Raymundi AM; Rodrigues da Silva T; Salemme BW; Batista Sohn JM; Araújo FS; Guimarães FS; Bertoglio LJ; Stern CA
Neuropharmacology; 2021 Sep; 196():108684. PubMed ID: 34181978
[TBL] [Abstract][Full Text] [Related]
11. The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.
Jamontt JM; Molleman A; Pertwee RG; Parsons ME
Br J Pharmacol; 2010 Jun; 160(3):712-23. PubMed ID: 20590574
[TBL] [Abstract][Full Text] [Related]
12. How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review.
Freeman AM; Petrilli K; Lees R; Hindocha C; Mokrysz C; Curran HV; Saunders R; Freeman TP
Neurosci Biobehav Rev; 2019 Dec; 107():696-712. PubMed ID: 31580839
[TBL] [Abstract][Full Text] [Related]
13. Neural correlates of interactions between cannabidiol and Δ(9) -tetrahydrocannabinol in mice: implications for medical cannabis.
Todd SM; Arnold JC
Br J Pharmacol; 2016 Jan; 173(1):53-65. PubMed ID: 26377899
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol-Δ
Britch SC; Wiley JL; Yu Z; Clowers BH; Craft RM
Drug Alcohol Depend; 2017 Jun; 175():187-197. PubMed ID: 28445853
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol modulation of antinociceptive tolerance to Δ
Greene NZ; Wiley JL; Yu Z; Clowers BH; Craft RM
Psychopharmacology (Berl); 2018 Nov; 235(11):3289-3302. PubMed ID: 30238130
[TBL] [Abstract][Full Text] [Related]
16. Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ(9) -tetrahydrocannabinol in Sprague-Dawley rats.
Taffe MA; Creehan KM; Vandewater SA
Br J Pharmacol; 2015 Apr; 172(7):1783-91. PubMed ID: 25425111
[TBL] [Abstract][Full Text] [Related]
17. Effects of daily Δ
Withey SL; Kangas BD; Charles S; Gumbert AB; Eisold JE; George SR; Bergman J; Madras BK
Drug Alcohol Depend; 2021 Apr; 221():108629. PubMed ID: 33640678
[TBL] [Abstract][Full Text] [Related]
18. Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats.
Javadi-Paydar M; Nguyen JD; Kerr TM; Grant Y; Vandewater SA; Cole M; Taffe MA
Psychopharmacology (Berl); 2018 Sep; 235(9):2541-2557. PubMed ID: 29907926
[TBL] [Abstract][Full Text] [Related]
19. Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew).
Parker LA; Kwiatkowska M; Burton P; Mechoulam R
Psychopharmacology (Berl); 2004 Jan; 171(2):156-61. PubMed ID: 13680081
[TBL] [Abstract][Full Text] [Related]
20. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat.
Murphy LL; Steger RW; Smith MS; Bartke A
Neuroendocrinology; 1990 Oct; 52(4):316-21. PubMed ID: 1979838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]